ArticleProceedings of the National Academy of Sciences of the United States of America2011

PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis.

Nina Ilic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.